Tech Company Financing Transactions

Sentien Biotechnologies Funding Round

Sentien Biotechnologies closed a $12 million Series A funding round on 4/5/2017. Investors included Boehringer Ingelheim Venture Fund, Chiesi Ventures and Mass Medical Angels.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Medical Devices & Instruments

Mailing Address

99 Hayden Ave. Building E 140
Lexington, MA 02421
USA

Phone

(781) 361-9031

Website

www.sentienbiotech.com

Email Address

[email protected]

Overview

Sentien has developed proprietary cell compositions and GMP manufacturing methods to advance combination products that unlock the potential of cell therapy.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chairman

Richard Ganz

        

Chief Executive Officer

Brian Miller

        

Co-Founder

Biju Parekkadan

        

Browse more venture capital transactions:

Prev: 4/5/2017: Micell Technologies venture capital transaction
Next: 4/5/2017: Amino venture capital transaction

Share this article

About Our VC Transactions Data

We do our best to report on all VC transactions involving tech companies. VC investment data records reported here come from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary